Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

An international panel of experts led by NDORMS researchers has developed a reporting guideline which supports the reporting quality of patent landscapes, ultimately promoting better informed decision-making in technology development and research direction.

Patent landscapes are overviews of the patenting activity in a particular field of technology, locally or globally, and provide unique and valuable insights to government, industry or research leaders.

They help key stakeholders identify new areas for research and development and are used to inform policy discussions, strategic research planning and technology transfer.

With patent landscapes often forming the basis of future research agendas in any given field, and informing next steps in technological investment, it is critical we deliver excellent quality patent landscape articles and reports.

The reporting checklist “Reporting Items for Patent Landscapes” (RIPL), published in Nature Biotechnology, offers a framework for articles published in academic journals through a consensus-based set of minimum criteria to include in patent landscape articles. Not only does RIPL provide straightforward and robust support for authors and editors, but its take-up also aids reproducibility and evidence synthesis.

“We want to improve the reporting of patent landscapes to ensure their societal impact is as significant as it can be. The reporting guidelines we have developed aim to do just that by providing support for authors, reviewers and editors working on patent landscape articles.” says Professor Andrew Carr.

Many patent landscapes are now gaining widespread attention through publication in high-impact journals, but unfortunately recent research showed their reporting to be inadequate.

Professor Carr adds: “In addition to authors and editors using RIPL, journal endorsement of the guidelines would encourage adherence and provide a uniform set of requirements for authors publishing in the field. We hope journals are watching this space.”

Reporting guidelines are commonly used in publications of health and biomedical research, where they have shown to improve reporting quality and ultimately lead to better, more transparent research with greater potential for impact.

The guideline has been registered with the EQUATOR Network, an international initiative that seeks to improve the reliability and value of published health research literature by promoting transparent and accurate reporting and wider use of robust reporting guidelines.

Read the full paper

The Reporting Items for Patent Landscapes statement

Nature Biotechnology volume36pages10431047 (2018)

Similar stories

Immunology preprint reviews launched in Nature Reviews Immunology

Kennedy Main Research

The Oxford-Mount Sinai (OxMS) Preprint Journal Club has partnered with Nature Reviews Immunology to launch a monthly Preprint Watch column.

A more tailored approach to treating psoriatic arthritis

Arthritis Botnar Funding Main

Dr Laura Coates has been awarded £1.8M from the National Institute for Health Research (NIHR) to explore the potential for precision medicine in the choice of biologics to reduce inflammation and pain in psoriatic arthritis.

Motion-capture to help children walk: Oxford team support new gait laboratory in Ethiopia

Main Orthopaedics and trauma

The Research at Oxford on Analysis of Motion (ROAM) team at the University of Oxford have supported CURE Ethiopia Children’s Hospital to develop and open a brand new gait laboratory, the first of its kind in the country and the only other active gait lab on the African continent outside of South Africa.

Professor Eleanor Stride recognised in New Year’s Honours list 2021

Awards Main

Statutory Professor of Biomaterials is awarded Officer of the Order of the British Empire (OBE) for services to Engineering

Drug may boost vaccine responses in older adults

Kennedy Main

A preliminary study shows that a drug which helps immune cells self-clean may improve vaccine protection in older adults

Living reviews launched by Oxford and Cardiff in the wake of COVID-19 research

Kennedy Main Research

In a combined effort to help COVID-19 researchers the University of Oxford and Cardiff University have launched a series of “living reviews” in Oxford University Press’s new open access journal “Oxford Open Immunology”.